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BY-NC-ND license (http://creativecomBackground/Purpose: To report the recurrence rate and cosmetic results of conjunctival
wound edge and caruncle, and complications after pterygium extended removal followed by
fibrin glue-assisted amniotic membrane transplantation.
Methods: A prospective interventional cohort study enrolled 57 (58 eyes) patients undergoing
pterygium extended removal followed by fibrin glue-assisted amniotic membrane transplanta-
tion. All patients received postoperative follow-up for at least 12 months. Recurrence rate was
graded from 1 to 4, and cosmetic results of conjunctival edge and caruncle were graded from 1
to 5.
Results: The cohort included 48 eyes with nasal pterygium, 5 eyes with temporal pterygium,
and 5 eyes with double pterygium. There were 81.0% (nZ 47), 0% (nZ 0), 12% (nZ 7), and 7%
(nZ 4) of eyes with Grades 1e4 recurrence, respectively. The cosmetic results of conjunc-
tival wound edge and caruncle in cases with nasal pterygium showed 59.3% (nZ 32), 14.8%
(nZ 8), 9.3% (nZ 5), 16.6% (nZ 9), and 0% (nZ 0) of eyes with Grades 1e5 morphology,
respectively. Overall, 5.1% (nZ 3), 3.4% (nZ 2), 3.4% (nZ 2), 3.4% (nZ 2), 1.7% (nZ 1),
6.9% (nZ 4), and 1.7% (nZ 1) of patients suffered from postoperative pyogenic granuloma,
transient diplopia, permanent motility restriction, steroid glaucoma, fat prolapse, subamnio-
tic membrane hemorrhage, and early detachment of amniotic membrane, respectively.have no commercial proprietary interest in the products or companies mentioned in the article.
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transplantation results in low recurrence, satisfactory cosmetic results and a low incidence of
additional complications.
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Pterygium is a common ocular disorder with a tendency for
recurrence after surgical removal. In addition to the simple
pterygium removal leading to bare sclera, several adjunc-
tive procedures have been developed with the goal of pre-
venting pterygium recurrence after surgery.1 Among these
strategies, mitomycin C application, b-irradiation, amniotic
membrane transplantation, and conjunctival trans-
plantation are well-accepted procedures.2 However, these
techniques are associated with their own complications. In
addition to these adjunctive therapies, other surgical fac-
tors can also affect the postoperative recurrence rate.2 The
extent of Tenon’s layer removal underneath the conjunc-
tival edge after pterygium removal is an issue under
debate.3,4 Extended removal of Tenon’s layer has been
proposed in the pterygium extended removal followed by
extended conjunctival transplantation (P.E.R.F.E.C.T.)
method, developed by Hirst.5,6 The P.E.R.F.E.C.T. method
consists of extended pterygium and Tenon’s layer removal
followed by extended autologous conjunctival trans-
plantation obtained from the superior bulbar conjunctiva,
demonstrated low recurrence, and satisfactory cosmetic
results for both primary and recurrent pterygia. Although
the results with this technique provide a promising way to
treat pterygium, this procedure has drawbacks such as
lengthier operative time, more complex procedures, and
additional damage to the healthy superior conjunctiva.7
Finding a way to preserve the advantages of P.E.R.F.E.C.T.
and reduce its drawbacks is clinically important.
Herein, we report the results of a prospective study in
which the Tenon’s layer was extensively removed, while
fibrin glue-assisted amniotic membrane transplantation
instead of conjunctival autograft was performed to cover
the bare sclera after removal of pterygium and Tenon’s
layer. Patients were followed-up for at least 12 months,
and the recurrence rate, cosmetic results of conjunctival
wound edge and caruncle, and additional complications
were analyzed.Methods
A prospective study in 57 consecutive patients who sought
treatment in the clinic of the author (W.L.C.) was per-
formed. All patients warranted excision of their pterygium
for either corneal invasion more than 3 mm and/or strong
request for cosmesis. Surgery was performed by a single
surgeon (W.L.C.) in the Department of Ophthalmology,
National Taiwan University Hospital, Taipei, Taiwan be-
tween July 2011 and January 2013. This study wasconducted in accordance with the Declaration of Helsinki
and approved by an Institutional Review Board of the Na-
tional Taiwan University Hospital (protocol approval num-
ber: 200910010M). Complete ophthalmologic examinations,
including slit-lamp examination, intraocular pressure mea-
surement, and dilated fundus examination were performed
before the surgery. External eye photography was taken
before and after the operation for record purposes. Each
patient was followed-up for at least 12 months.
Surgical technique
The technique included extended removal of the pteyrgium
by the method of Hirst5,6, but followed by amniotic mem-
brane transplantation instead of conjunctival autograft.
Anesthesia was initiated with 0.5% proparacaine hydro-
chloride (Alcaine, Alcon-Couvreur, Puurs, Belgium) topi-
cally followed by peribulbar anesthesia with 2% lidocaine
hydrochloride (Xylocaine, Recipharm, Monts, France).
Lamellar keratectomy was performed meticulously using a
No. 64 crescent knife to remove the pterygium head on the
corneal surface. The body of the pterygium which included
the conjunctiva and underlying Tenon’s layer was excised.
The recipient bed previously covered by pterygium was
then prepared for subsequent amniotic membrane trans-
plantation. The Tenon’s layer, near the superior and infe-
rior recti and back to the caruncle, was isolated by
undermining the two surgical planes: one between Tenon’s
layer and sclera, and the other between the conjunctiva
and Tenon’s layer. After identifying and securing the medial
rectus insertions with a muscle hook, Tenon’s layer was
carefully excised using Westcott Tenotomy Scissors
(without damage to the rectus muscles). The semilunar fold
was excised leaving a bare sclera, approximately 14 mm 
14 mm, measuring from the limbus to the paracaruncular
edge of conjunctiva. A surgical sponge soaked with mito-
mycin C (2 mg/10 mL) was placed on the exposed sclera for
2 minutes followed by vigorous irrigation with normal sa-
line. Amniotic membrane was obtained from the tissue
bank of the National Taiwan University Hospital. The pre-
pared amniotic membrane was then applied on the bare
sclera with the assistance of fibrin glue (Tissueco Duo
Quick, Baxter, IL, USA) between the amniotic membrane
and bare sclera for fixation. The amniotic membrane
attached firmly to the bare sclera within 15 seconds. To
prevent graft detachment in a relatively large size of am-
niotic membrane, three stitches of 10-0 nylon suture were
anchored to the limbus for strengthening the amniotic
membrane attachment, and two stitches of 8-0 polyglactin
910 sutures were used to anchor the superior/inferior
conjunctival wound edge, episcleral tissue, and the edge of
Table 2 The grading system of postoperative conjunctival
wound edge/caruncular morphology in nasal pterygium.
Grade 1 A normal appearance.
Grade 2 Focal synechia of conjunctival wound edge to
the amniotic membrane covered area without
thickening of conjunctival wound edge or change
of caruncle location.
Grade 3 Thickened conjunctival wound edge without
obvious adhesion or change of caruncular
morphology.
Grade 4 Diffuse synechia of conjunctival wound edge
to the amniotic membrane covered area with
anterior advancement of caruncle location
< 3 mm.
Grade 5 Diffuse synechia of conjunctival wound edge
to the amniotic membrane covered area with
anterior advancement of caruncle location
> 3 mm.
12 H.-Y. Liu et al.the amniotic membrane 3 mm from the limbus. A thera-
peutic contact lens was applied at the end of the surgery.
Postoperative follow-up
All patients wore therapeutic contact lenses for 1 week
after surgery. Acetaminophen 500 mg, as needed (maximal
daily dose 2g), was administered as oral analgesia for the
first 7 days and topical 0.1% betamethasone sodium phos-
phate (Betame, AI Medicine, Taoyuan, Taiwan) was used
four times daily for 1 month, tapered to two times a day for
1 month, once a day until the postoperative 3rd month.
Patients were followed-up at the 1st postoperative day, 1e2
weeks later, 1 month later, and three more times over the
1st year after surgery. These visits were supplemented if
the clinical course suggested any acute problems. All su-
tures were removed within 2 weeks after surgery. During
each visit, external eye photography, intraocular pressure,
slit-lamp biomicroscopy, and routine visual acuity testing
were performed.
Grading of recurrence, and cosmetic classification
of conjunctival edge and caruncle
The grading of postoperative recurrence was performed by
a single investigator (H.Y.L.) on the basis of a grading sys-
tem (on a scale of 1e4) as previously described by Prab-
hasawat et al,8 with some modifications (Table 1). Grade 4
was defined as a true recurrence in this study with fibro-
vascular tissue across the limbus. In addition, we set up a
new classification system ranging from Grade 1 to Grade 5
to describe the postoperative cosmetic results of the
conjunctival wound edge and caruncle for patients with
nasal pterygium (Table 2 and Figure 1). Grades 1e3 were
defined as acceptable cosmetic outcomes in this study.
Additional complications
In addition to recurrence and cosmetic results on
conjunctival edge and caruncle, other complications such
as pyogenic granuloma, transient diplopia, permanent
motility restriction, steroid-induced glaucoma, fat pro-
lapse, subamniotic hematoma, and detachment of the
amniotic membrane were regarded as additional compli-
cations in this study (Figure 2). Transient diplopia was
defined as postoperative diplopia which recovered sponta-
neously within 3 months, while permanent motilityTable 1 The grading system of postoperative recurrence
of pterygium.
Grade 1 A normal appearance of the operated site.
Grade 2 The presence of fine episcleral vessels in the
excised area extending to the limbus but
without any fibrous tissue.
Grade 3 Fibrovascular tissue in the excised area reaching
to the limbus but not invading the cornea.
Grade 4 A true corneal recurrence, with fibrovascular
tissue invading the cornea & across the limbus.restriction indicates diplopia which persists 3 months after
surgery.
Statistical analysis
Continuous variables were presented as mean standard
deviation. To identify the risk factors associated with the
additional complications mentioned above, c2 test or
Fisher’s exact test were performed as appropriate. A mul-
tiple lineal regression analysis was performed to factors
related to the recurrence of pterygium after the surgery:
age, sex, laterality, and primary or recurrent pterygium. All
of the statistical analyses were performed using STATA 8.2
software (StataCorp LP, College Station, TX, USA). A p value
< 0.05 was considered statistically significant.
Results
The basic profile of patients in the study is shown in Table
3. Fifty-eight eyes in 57 patients were included in this
study. A great majority of patients belonged to the inter-
mediate or fleshy type of pterygium. Pterygium was diag-
nosed in 27 (47%) right eyes and 31 (53%) left eyes. The
male-to-female ratio was 28:29, with a mean age of
61.6 12.0 years (range, 33e88 years). Forty eyes had
primary pterygium and 18 eyes had recurrent pterygium. All
the patients in our study had pterygium extending onto the
cornea more than 3 mm. In cases that had pterygium sur-
geries previously, the interval between the two operations
was > 1 year. The mean follow-up was 26.2 11.9 months
(range, 12.1e51.2 months).
The postoperative course was associated with mild pain
for 1e3 days requiring oral analgesia for the first 24 hours.
The therapeutic contact lenses were all removed 2 weeks
postoperatively, and no corneal epithelial defects
remained at that time. Total epithelialization on the am-
niotic membrane was found within the first 3 weeks after
the surgery. Three weeks following the operation, the
majority of patients felt no pain and the operated eyes
Figure 1 The normal temporal conjunctival wound edge after the operation, and the grading of nasal wound edge and caruncular
morphology after operation, (A) The normal temporal conjunctival wound edge after operation; (B) Grade 1 conjunctival wound
edge (arrow) and normal caruncular morphology at nasal canthus; (C) Grade 2 shows obvious focal adhesion of the conjunctival
edge (thin arrow) to the underlying tissue without obvious change of morphology and location of caruncle (thick arrow); (D) Grade 3
shows thickening of conjunctival wound edge (arrow) without obvious change of morphology and location of caruncle; (E) Grade 4
shows diffuse synechia of conjunctival wound edge (thin arrow) to the amniotic membrane covered area with anterior advance-
ment of caruncle location < 3 mm (thick arrow); and (F) Grade 5 shows diffuse synechia of conjunctival wound edge (thin arrow) to
the amniotic membrane covered area with anterior advancement of caruncle location > 3 mm (thick arrow).
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months after surgery.
The postoperative recurrence rates evaluated at the last
visit are shown in Table 4. 81.0% (nZ 47), 0% (nZ 0), 13.8%
(nZ 7), and 6.9% (nZ 4) of patients were found to have
Grades 1e4 recurrence, respectively. Regarding the
cosmetic results of nasal conjunctival wound edge and
caruncle, 59.3% (nZ 32), 14.8% (nZ 8), 9.3% (nZ 5),
16.6% (nZ 9), and 0% (nZ 0) of patients were found to
have Grades 1e5 morphology, respectively. Overall, 5.1%
(nZ 3), 3.4% (nZ 2), 3.4% (nZ 2), 3.4% (nZ 2), 1.7%
(nZ 1), 6.9% (nZ 4), and 1.7% (nZ 1) of patients suffered
from postoperative pyogenic granuloma, transient diplopia,
permanent motility restriction, steroid-induced glaucoma,
fat prolapse, subamniotic membrane hemorrhage, and
early detachment of amniotic membrane, respectively, as
shown in Table 4.
Those cases with pyogenic granuloma and subamniotic
membrane hematoma improved under a topical cortico-
steroid course within 2 months. Both patients withtransient diplopia recovered without sequels within 3
months. Two cases had permanent motility restriction after
the operation and both had Grade 4 conjunctival wound
edge and caruncle pattern. One case had detachment of
the amniotic membrane at postoperative Day 3 due to eye
rubbing and received surgery to reattach the graft without
further complications.Statistical results
The prognostic factors for recurrence and cosmetic results
on conjunctival edge and caruncle by univariate and mul-
tiple analyses are listed in Tables 5 and 6, respectively.
Despite that older persons achieved significantly better
cosmetic results regarding the conjunctival edge and
caruncle, older age is not associated with reduced recur-
rence. Moreover, there were no statistical associations of
sex, primary or recurrent pterygium, or laterality with
postoperative pterygium recurrence (all p > 0.05). Only
Figure 2 (A) Pyogenic granuloma in a Grade 4 caruncle; (B) subamniotic membrane hemorrhage; (C) fat prolapse at the caruncle;
and (D) synechia of the caruncluar area with limitation of ocular motility limitation.
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currence in our multiple linear regression analysis model
(pZ 0.07). There were no significant risk factors found
associated with the additional complications (all p > 0.05).Discussion
Recurrence after pterygium removal remains a major
challenge for ophthalmologists, as evidenced by the
numerous surgical methods that have been developed to
treat this condition over the years.9e11 Among which, the
P.E.R.F.E.C.T. method demonstrated a high success rate,
which was claimed to be due to the extended removal of
the pterygium and Tenon’s layer.5,6 However, the techni-
cally challenging procedure that sacrifices a large area of
healthy superior conjunctiva remains a major drawback of
this procedure. In this study we developed a method named
as pterygium extended removal followed by amniotic
membrane transplantation (P.E.R.F.A.M.T.), which containsTable 3 Biographical details of the population.
Total Primary
No. of eyes 58 eyes 40 eyes in 40 pts (3
pterygium; 3 with te
OD/OS 27/31 20/20
Laterality* (N/T) 54/9 37/6
Sex (M/F) 28/29 22/18
Age (y) 61.6 12.0 (33e88) 60.2 12.3 (33e88)
Follow-up (mo) 26.2 11.9 (12.1e51.2) 27.3 10.4 (12.07e
Data are presented as mean standard deviation (range) unless othe
FZ female; MZmale; NZ nasal; ODZ right eye; OSZ left eye; pts
* Eyes with double pterygium are excluded.the benefit of extended pterygium and Tenon’s layer
removal as P.E.R.F.E.C.T., but avoids the disadvantage of
damaging large areas of healthy conjunctiva as the source
of donor graft. With the aid of fibrin glue-assisted amniotic
membrane transplantation to cover the large area of bare
sclera, the procedure was simple, less traumatic, and more
surgeon/patient friendly.
Tracing back the history of pterygium surgery, simple
bare scleral surgery has been used for more than half of the
20th century as the basic component of pterygium surgery.12
The area of bare sclera created during surgery may play an
important role in pterygium recurrence.2 The reason we
adopted extended pterygium and Tenon’s layer removal
was based on the hypothesis that Tenon’s layer remained a
major source of recurrent pterygium. Kamel13 proposed
that removal of Tenon’s layer may be important in reducing
recurrence after pterygium removal. This strategy has also
been emphasized by Solomon et al,14 who combined this
technique with mitomycin C and amniotic membrane to
achieve low recurrence rate. The extensive removal ofRecurrent
with double
mporal pterygium)
18 eyes in 18 pts (2 with double
pterygium; 1 with temporal pterygium)
7/11
17/3
7/11
64.9 10.4 (43e84)
51.16) 23.8 12.4 (12.33e51.16)
rwise indicated.
Z patients; TZ temporal.
Table 4 Postoperative recurrence, conjunctival wound
edge/caruncle morphology in nasal pterygium, and addi-
tional complications.
Grading of postoperative recurrence, n/N (%)
Grade 1 47/58 (81)
Grade 2 0
Grade 3 7/58 (12)
Grade 4 4/58 (7)
Grading of postoperative conjunctival wound
edge/caruncular morphology
Grade 1 32/54 (59.3)
Grade 2 8/54 (14.8)
Grade 3 5/54 (9.3)
Grade 4 9/54 (16.6)
Grade 5 0
Additional complications
Pyogenic granuloma 3/58 (5.1)
Transient diplopia 2/58 (3.4)
Permanent motility restriction 2/58 (3.4)
Steroid-induced glaucoma 2/58 (3.4)
Fat prolapsed 1/58 (1.7)
Subamniotic membrane hematoma 4/58 (6.9)
Early detachment of amniotic membrane 1/58 (1.7)
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conjunctival defect, may well be the reason for the zero
recurrence rate reported using the P.E.R.F.E.C.T.
method.5,6 However, the application of intra-operative
mitomycin C and topical steroid postoperatively may also
play a part in reducing recurrence. Studies by Kheirkhah
et al15,16 demonstrated that amniotic membrane combinedFigure 3 The representative photos at 6-months after the pte
transplantation procedure from a 67 year-old man with double pter
extending across the limbus; (B) postoperative 6-month picture
appearance of pterygium; (C) the postoperative 6-month photogr
conjunctiva; and (D) the postoperative 6-month photograph demonwith mitomycin C use has similar outcomes and complica-
tion rates to conjunctival autograft with mitomycin C in
patients with recurrent pterygium. In addition, the anti-
proliferative and anti-inflammatory actions of mitomycin C
may reduce the scarring of conjunctiva and thus allow
better cosmesis.17
One important procedure to be combined with bare
scleral pterygium removal involved covering the bare
scleral area with conjunctival autograft or amniotic mem-
brane. The superior or inferior bulbar conjunctiva can both
be used as the donor grafts.10,18 Although the postoperative
recurrence rate and cosmetic results after conjunctival
transplantation are promising, both superior or inferior
bulbar conjunctiva transplantation have common draw-
backs such as being a lengthy and complex procedure due
to graft harvest and graft attachment by suture.19,20
Furthermore, the damage of the superior conjunctiva may
make further glaucoma filtering surgery impossible.21 In the
techniques of extended pterygium and Tenon’s layer
removal, even larger areas of unexposed sclera will inevi-
tably be created. Conjunctival grafts with such large areas
can exacerbate the situation. Amniotic membrane graft has
been used as an effective alternative to conjunctival
autograft in pterygium surgery due to its anti-inflammatory
and antifibrotic properties, as well as its ability to promote
the differentiation and migration of epithelial cells.11 In
addition, amniotic membrane graft is safely and abundantly
supplied by the tissue bank. Although not yet fully proven,
the texture of amniotic membrane, its anti-inflammatory
property,22,23 and the tissue availability may make amnio-
tic membrane graft an alternative and noninferior to
conjunctival autograft, since the latter might be limited by
the lack of remaining healthy tissue and usually has Tenon’srygium extended removal followed by extended conjunctival
ygium: (A) preoperative picture shows double pterygium, both
shows a silent ocular surface with Grade 1 postoperative
aph demonstrates a satisfactory appearance of the temporal
strates a Grade 1 caruncular appearance.
Table 5 Lineal regression analyses of risk factors associ-
ated with pterygium recurrence.
Analysis (nZ 58) Coefficient (95% CI) p*
Univariate logistic regression
Age (per y) 0.01(0.04e0.01) 0.17
Sex (M vs. F) 0.14(0.65e0.37) 0.59
Primary or recurrent 0.49 (1.02e0.05) 0.07
Laterality (nasal vs.
temporal vs. bilateral)
0.17(0.74e1.07) 0.72
Stepwise multivariate regression
Laterality (nasal vs.
temporal vs. bilateral)
0.50 (1.04e0.03) 0.07
*p < 0.05 was considered to be statistically significant.
CIZ confidential interval; FZ female; MZmale.
16 H.-Y. Liu et al.layer which can be difficult to remove completely. The
application of fibrin glue that assisted P.E.R.F.A.M.T. in this
study may provide a quick, nontraumatic, and even safer
way than P.E.R.F.EC.T. for treating pterygium.
P.E.R.F.A.M.T. may allow for a decreased number of sutures
or no sutures, and avoid complicated manipulation around
the caruncular area. Reviewing the literature, the
conjunctival grafting method has a recurrence rate be-
tween 5% and 15% while the amniotic grafting method re-
sults in a wide range of recurrence rates, from 5% to
64%.8,24,25 However, the varying severity of pterygium,
extent of Tenon’s tissue removal, observation period, and
the usage of adjuvant medication may all affect the surgi-
cal results, and make comparisons difficult. Unlike the zero
recurrence rate in P.E.R.F.E.C.T. surgery published by
Hirst,5,6 our results showed a true recurrence rate of 6.6%,
which was less than, or at least comparable, to the previous
studies.8,24,25 Whether this was caused by the different
transplanted tissue or other factors, remains to be
evaluated.
Successful pterygium surgery is based on a low recur-
rence rate and good cosmetic outcome. Most studies have
only focused on the recurrence of pterygium, which may
not truly reflect the patients’ satisfaction after the surgery.
Trying to improve cosmetic dissatisfaction is still important.
In the technique of pterygium extended removal, which
involved the manipulation of rectus muscle, caruncle, andTable 6 Lineal regression analyses of risk factors associ-
ated with cosmetic results on conjunctival edge and
caruncle.
Analysis (nZ 54) Coefficient (95% CI) p*
Univariate logistic regression
Age (per y) 0.03(0.64e0.01) 0.007
Sex (M vs. F) 0.14(0.75e0.47) 0.65
Primary or recurrent 0.32 (1.05e0.30) 0.30
Laterality (nasal vs.
temporal vs. bilateral)
0.43(1.51e0.65) 0.43
Stepwise multivariate regression
Age (per y) 0.03 (0.06e0.01) 0.007
* p < 0.05 was considered to be statistically significant.
CIZ confidential interval; FZ female; MZmale.semilunar fold, the cosmetic morphology of conjunctival
edge and caruncle are especially important. In this study,
we designed a classification system for the conjunctival
edge and caruncle morphological characteristics. Nine eyes
suffered from Grade 4 patterns of conjunctival edge and
caruncular morphology. It has been known that multiple
factors contribute to recurrence.26 Although we found age
is associated with cosmetic outcome (Table 5), other fac-
tors may prevail over age in terms of recurrence. Older
patients had better cosmetic patterns of the nasal
conjunctival edge and caruncle after surgery (Table 6). We
considered age-related alternations in wound healing pro-
cess and mitomycin C use may partly explain the finding.
The four phases of wound healing (hemostasis, inflamma-
tion, proliferation, and resolution) have been studied and
exhibit characteristic changes with aging.27 Decreased
levels of growth factors, diminished cell proliferation and
migration, and diminished extracellular matrix secretion
have been demonstrated during aging process.28 Since
inflammation and fibroblast proliferation both play a role in
wound scarring, the decreased response with aging and the
anti-inflammatory and antiproliferative effects of mito-
mycin C may reduce the chance of scar formation.
Additional complications in this study included pyogenic
granuloma, transient diplopia, permanent motility restric-
tion, steroid-induced glaucoma, fat prolapse, subamniotic
membrane hemorrhage, and early detachment of the am-
niotic membrane. Most of the complications were mild and
transient, except two cases of permanent motility restric-
tion. Both cases with permanent motility restriction had
mild motility restriction before the operation. The severity
of motility restriction before and after the surgery was
comparable to each other. A Grade 4 conjunctival wound
edge/caruncular morphology was noted in the two cases
and conjunctival adhesion was considered as the major
cause for motility restriction rather than damage to the
medial rectus. Although rare, extensive damage to the
caruncular area may lead to cicatricial motility restriction,
which is difficult to manage.29 The possibility of iatrogenic
orbital fat prolapse should be avoided.30 Carefully handling
the tissue around the caruncle and conjunctival edge
combined with long-term and adequate steroids should be
emphasized in extended pterygium and conjunctival
resection, such as P.E.R.F.E.C.T. and P.E.R.F.A.M.T.
In conclusion, we developed a surgical method called
P.E.R.F.A.M.T., and demonstrated its advantage for the
surgical treatment of pterygium. The low recurrence rate,
high cosmetic satisfaction, and low additional complication
rate demonstrate that P.E.R.F.A.M.T. is a reliable
procedure.
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